MMP2 and neoplasm: However, matrix metalloproteinases (MMPs) including MMP-2 and MMP-9 showed significant decrease after ApoA-1 treatment in both two cell lines, which indicating ApoA-1 might inhibit CTC formation via impairing extracellular matrix degradation properties of tumor cells.